Endometrial cancer study comparing old and new staging systems
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at tissue samples and medical records of people with endometrial cancer who had surgery between 2018 and 2022. It aims to compare older and newer ways of describing the cancer stage to help improve treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had surgery to remove your uterus and ovaries (total hysterectomy and bilateral salpingo-oophorectomy) between January 2018 and December 2022.
- You received treatment after surgery (like chemotherapy or radiation).
- Your medical records and tissue samples from surgery are still available for researchers to look at.
- You have been followed for at least two years after diagnosis.
- You did not get chemotherapy before your surgery, your cancer did not come back, and you have not had another cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies tumor DNA in blood and tissue from people with aggressive endometrial cancer to better understand the disease. You donate samples during surgery and follow-up visits.
This trial compares two surgical approaches for treating endometrial cancer: traditional open surgery (laparotomy) versus minimally invasive keyhole surgery (laparoscopy). The goal is to determine which method is safer and more effective for removing the uterus, ovaries, and lymph nodes while staging the cancer.
This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.
This trial compares two surgical approaches for early-stage endometrial cancer: a less invasive laparoscopic method and a traditional open surgery. The goal is to see if the laparoscopic approach is as effective with potentially faster recovery.
This study uses a genetic test (looking at the DNA of the tumor) to better understand endometrial cancer. The goal is to improve how doctors classify and potentially treat this cancer, especially for those with advanced stages or certain subtypes.
This is a research study that looks at outcomes in women with endometrial (uterine) cancer who receive the usual standard surgery. Researchers will group patients based on the final surgical and pathology results and what additional (if any) treatment is recommended afterward.
Hear when a new Endometrial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.